Medical devices, healthcare technology and the business of care
510(k) clearance · K261778

JADE SCORE PTA Scoring Balloon Dilatation Catheter

OrbusNeich Medical (Shenzhen) Co., Ltd. · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK261778

What did the FDA decide?

FDA's 510(k) database records K261778 as a traditional premarket notification from OrbusNeich Medical (Shenzhen) Co., Ltd. for the JADE SCORE PTA Scoring Balloon Dilatation Catheter, classified under 21 CFR 870.1250 (Catheter, Percutaneous, Cutting/Scoring), product code PNO, in the Cardiovascular specialty. The decision is Substantially Equivalent (SESE), dated September 16, 2026, which is a clearance to market rather than a PMA approval. The database lists a received date of May 29, 2026, while the clearance letter states the submission was dated and received August 13, 2026; the source does not reconcile the discrepancy.

The 510(k) summary describes two versions: a 14 Rx rapid-exchange configuration for 0.014-inch guidewires and an 18 OTW over-the-wire configuration for 0.018-inch guidewires. It names the UltraScore Focused Force PTA Balloon (K163420) as predicate and Scoreflex (K182713) and JADE PLUS (K241025) as reference devices, citing the same indications, hydrophilic coating, scoring element and EO sterilization, with differences limited to specific materials and component dimensions. The summary states in vitro tests met acceptance criteria; no clinical outcome data are presented, and the enclosure's age-group selections are not legible in the provided text.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261778
Regulatory pathway
510(k) premarket notification
Product code
PNO
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Percutaneous, Cutting/Scoring.

Product code
PNO
FDA device class
2

FDA decision timeline

  1. K261778 received

    Application receipt date recorded by FDA.

  2. K261778 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PNO

Product / regulatory recordCompanyPathwayDecision dateSource
Zylox Medtech Co., Ltd.510(k) clearanceOct 22, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

OrbusNeich Medical (Shenzhen) Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records